Log In
Print this Print this

Lupuzor, rigerimod (SyB L-1001) (CEP-33457) (formerly IPP-201101)

Also known as: forigerimod

  Manage Alerts
Collapse Summary General Information
Company ImmuPharma plc
DescriptionPeptide fragment analog including residues 131-151 of the spliceosomal U1-70K protein with a phosphorylated serine at position 140
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation U.S. - Fast Track (Treat systemic lupus erythematosus (SLE));
U.S. - Special Protocol Assessment (Treat systemic lupus erythematosus (SLE))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today